Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FEQCN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,551
Award facts
- Contract value 100% obligated
- $5,550.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,550.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100-unit vials. The contract, awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards predominantly from DLA covering an extensive array of medical products including prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's ability to compete effectively in federal procurement markets while maintaining its woman-owned small business status demonstrates its operational capacity to fulfill ongoing medical supply requirements for military health facilities. This Botox delivery order represents a routine fulfillment under the company's larger SPE2DB program contract framework, supporting the Department of Defense's pharmaceutical distribution needs.
Quick answers
Who was awarded contract SPE2DB25FEQCN?
SPE2DB25FEQCN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FEQCN worth?
The government has obligated $5,551 on SPE2DB25FEQCN.
Is contract SPE2DB25FEQCN an order under another contract?
Yes. SPE2DB25FEQCN is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB25FEQCN competed?
The extent of competition for SPE2DB25FEQCN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award